Walleye Trading’s GSK GSK Stock Holding History

Walleye Trading’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$977K	Sell	17,700 -124,500	-88%	-$6.75M	﹤0.01%	2178
2025 Q4	$6.97M	Buy	142,200 +109,300	+332%	+$5.1M	0.01%	1112
2025 Q3	$1.42M	Buy	32,900 +6,800	+26%	+$266K	﹤0.01%	2039
2025 Q2	$1M	Buy	26,100 +10,700	+69%	+$409K	﹤0.01%	2194
2025 Q1	$597K	Sell	15,400 -58,600	-79%	-$2.15M	﹤0.01%	2397
2024 Q4	$2.5M	Buy	74,000 +19,600	+36%	+$706K	0.01%	1552
2024 Q3	$2.22M	Buy	54,400 +24,800	+84%	+$1.01M	﹤0.01%	1612
2024 Q2	$1.14M	Buy	29,600 +9,100	+44%	+$383K	﹤0.01%	1972
2024 Q1	$879K	Sell	20,500 -30,800	-60%	-$1.27M	﹤0.01%	2354
2023 Q4	$1.9M	Sell	51,300 -23,500	-31%	-$844K	﹤0.01%	1966
2023 Q3	$2.71M	Sell	74,800 -21,300	-22%	-$756K	0.01%	1554
2023 Q2	$3.43M	Buy	96,100 +60,400	+169%	+$2.17M	0.01%	1245
2023 Q1	$1.27M	Sell	35,700 -73,200	-67%	-$2.56M	﹤0.01%	2034
2022 Q4	$3.83M	Buy	108,900 +61,900	+132%	+$2.06M	0.01%	1230
2022 Q3	$1.38M	Buy	47,000 +5,080	+12%	+$193K	﹤0.01%	1994
2022 Q2	$2.85M	Sell	41,920 -38,560	-48%	-$2.13M	0.01%	1394
2022 Q1	$4.38M	Sell	80,480 -26,400	-25%	-$1.43M	0.01%	1077
2021 Q4	$5.89M	Buy	106,880 +48,560	+83%	+$2.53M	0.02%	880
2021 Q3	$2.79M	Buy	58,320 +35,120	+151%	+$1.76M	0.01%	1341
2021 Q2	$1.16M	Buy	23,200 +10,160	+78%	+$488K	﹤0.01%	1999
2021 Q1	$582K	Sell	13,040 -320	-2%	-$14.5K	﹤0.01%	2489
2020 Q4	$615K	Sell	13,360 -34,880	-72%	-$1.6M	﹤0.01%	2477
2020 Q3	$2.27M	Buy	48,240 +32,880	+214%	+$1.65M	0.01%	1037
2020 Q2	$783K	Sell	15,360 -66,480	-81%	-$3.41M	0.01%	1876
2020 Q1	$3.88M	Buy	81,840 +14,000	+21%	+$747K	0.03%	498
2019 Q4	$3.98M	Buy	67,840 +57,360	+547%	+$3.19M	0.03%	708
2019 Q3	$559K	Sell	10,480 -12,960	-55%	-$667K	﹤0.01%	2041
2019 Q2	$1.17M	Sell	23,440 -26,000	-53%	-$1.3M	0.01%	1456
2019 Q1	$2.58M	Sell	49,440 -14,960	-23%	-$748K	0.02%	886
2018 Q4	$3.08M	Buy	64,400 +26,800	+71%	+$1.32M	0.02%	760
2018 Q3	$1.89M	Buy	37,600 +20,560	+121%	+$1.04M	0.01%	1394
2018 Q2	$859K	Sell	17,040 -18,800	-52%	-$947K	﹤0.01%	2272
2018 Q1	$1.75M	Buy	35,840 +1,120	+3%	+$52.2K	0.01%	1340
2017 Q4	$1.54K	Sell	34,720 -6,000	-15%	-$277K	0.01%	1533
2017 Q3	$2.07K	Sell	40,720 -134,320	-77%	-$6.81M	0.01%	1237
2017 Q2	$9.44K	Buy	175,040 +160,960	+1,143%	+$8.58M	0.06%	316
2017 Q1	$742	Sell	14,080 -78,800	-85%	-$4M	0.01%	1903
2016 Q4	$4.47M	Buy	92,880 +14,560	+19%	+$719K	0.03%	495
2016 Q3	$4.23M	Buy	78,320 +20,960	+37%	+$1.15M	0.03%	507
2016 Q2	$3.11M	Sell	57,360 -12,720	-18%	-$670K	0.02%	724
2016 Q1	$3.55M	Sell	70,080 -17,360	-20%	-$865K	0.03%	535
2015 Q4	$4.41M	Buy	87,440 +33,200	+61%	+$1.69M	0.04%	411
2015 Q3	$2.61M	Buy	54,240 +40,720	+301%	+$2.12M	0.02%	523
2015 Q2	$703K	Sell	13,520 -3,120	-19%	-$176K	0.01%	1391
2015 Q1	$961K	Sell	16,640 -2,080	-11%	-$119K	0.01%	1036
2014 Q4	$1M	Sell	18,720 -6,880	-27%	-$385K	0.01%	1036
2014 Q3	$1.47M	Buy	25,600 +14,480	+130%	+$888K	0.02%	609
2014 Q2	$741	Sell	11,120 -10,720	-49%	-$726K	0.01%	980
2014 Q1	$1.46K	Buy	21,840 +9,120	+72%	+$617K	0.02%	634
2013 Q4	$849K	Buy	12,720 +6,640	+109%	+$431K	0.01%	1213
2013 Q3	$381K	Buy	6,080 +2,800	+85%	+$180K	﹤0.01%	1365
2013 Q2	$205K	Buy	+3,280	New	+$208K	﹤0.01%	1695

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Walleye Trading's GSK Position: Q1 2026 in Review

Walleye Trading opened a new position in GSK (GSK) in Q1 2026: 118,561 shares worth $6.54M. The stake represents 0.01% of the portfolio and ranks #989 among its holdings. This is a return to the name: Walleye Trading previously reported a position in GSK as recently as Q3 2025.

Walleye Trading first reported a position in GSK in Q2 2013 and has held it in 27 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Walleye Trading held 118,561 shares of GSK worth $6.54M as of Q1 2026.
GSK was a new Walleye Trading position in Q1 2026.
GSK made up 0.01% of Walleye Trading's portfolio in Q1 2026, its #989 holding.
Walleye Trading first reported a position in GSK in Q2 2013 and has held it in 27 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.